Bart Welten
Nessuna posizione attualmente
Profilo
Bart Welten served as Chief Financial Officer at Avantium NV from 2020 to 2023, at DSM Resins BV from 2006 to 2012, and at Centrient Pharmaceuticals Netherlands BV in 2018-2019.
He also held the position of Chief Financial Officer at DSM Anti Infectives BV.
Mr. Welten holds an MBA from Boston College and an undergraduate degree from the University of Leiden.
Precedenti posizioni note di Bart Welten
Società | Posizione | Fine |
---|---|---|
AVANTIUM N.V. | Director of Finance/CFO | 01/01/2023 |
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Director of Finance/CFO | 01/02/2019 |
DSM Resins BV | Director of Finance/CFO | 01/07/2012 |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Director of Finance/CFO | - |
Formazione di Bart Welten
Boston College | Masters Business Admin |
University of Leiden | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AVANTIUM N.V. | Producer Manufacturing |
Aziende private | 3 |
---|---|
DSM Resins BV | |
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Health Technology |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Health Technology |
- Borsa valori
- Insiders
- Bart Welten